We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Updated: 12/31/1969
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated: 12/31/1969
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Updated: 12/31/1969
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Updated: 12/31/1969
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated: 12/31/1969
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Updated: 12/31/1969
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Updated: 12/31/1969
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated: 12/31/1969
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Updated: 12/31/1969
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Updated: 12/31/1969
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated: 12/31/1969
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Updated: 12/31/1969
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)
Updated: 12/31/1969
Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure
Status: Enrolling
Updated: 12/31/1969
PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)
Updated: 12/31/1969
Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Updated: 12/31/1969
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
PROMUS Element Plus US Post-Approval Study
Updated: 12/31/1969
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials